SG11201605532YA - Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical composition - Google Patents
Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical compositionInfo
- Publication number
- SG11201605532YA SG11201605532YA SG11201605532YA SG11201605532YA SG11201605532YA SG 11201605532Y A SG11201605532Y A SG 11201605532YA SG 11201605532Y A SG11201605532Y A SG 11201605532YA SG 11201605532Y A SG11201605532Y A SG 11201605532YA SG 11201605532Y A SG11201605532Y A SG 11201605532YA
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutical composition
- castor oil
- acid compound
- polyoxyethylene castor
- containing pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014002809 | 2014-01-10 | ||
| PCT/JP2015/050333 WO2015105134A1 (ja) | 2014-01-10 | 2015-01-08 | ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201605532YA true SG11201605532YA (en) | 2016-08-30 |
Family
ID=53523959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201605532YA SG11201605532YA (en) | 2014-01-10 | 2015-01-08 | Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical composition |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US20160317512A1 (ja) |
| EP (2) | EP3888654B1 (ja) |
| JP (5) | JP6012775B2 (ja) |
| KR (5) | KR102230683B1 (ja) |
| CN (2) | CN110251516B (ja) |
| AU (1) | AU2015205268B2 (ja) |
| BR (1) | BR112016015911B1 (ja) |
| CA (1) | CA2934612C (ja) |
| EA (1) | EA031723B1 (ja) |
| ES (2) | ES2953346T3 (ja) |
| GE (1) | GEP20186916B (ja) |
| HK (1) | HK1224191A1 (ja) |
| IL (1) | IL246654B (ja) |
| MX (1) | MX2016009058A (ja) |
| MY (1) | MY166210A (ja) |
| PH (1) | PH12016501327A1 (ja) |
| SG (1) | SG11201605532YA (ja) |
| TW (1) | TWI612960B (ja) |
| WO (1) | WO2015105134A1 (ja) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020003133A (es) * | 2014-01-10 | 2021-08-23 | Santen Pharmaceutical Co Ltd | Composicion farmaceutica que contiene compuesto de acido piridilaminoacetico. |
| KR101824829B1 (ko) | 2014-01-10 | 2018-02-01 | 산텐 세이야꾸 가부시키가이샤 | 피리딜아미노아세트산 화합물을 포함하는 의약 제제 |
| GEP20186916B (en) * | 2014-01-10 | 2018-11-12 | Pharmaceutical Co Ltd Santen | Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical composition |
| EP3320904B1 (en) | 2015-07-09 | 2023-07-05 | Santen Pharmaceutical Co., Ltd. | Preventative and/or therapeutic agent containing pyridyl aminoacetic acid compound for treating a disease involving a greatly elevated intraocular pressure |
| US20200121652A1 (en) | 2017-06-16 | 2020-04-23 | The Doshisha | Compounds having caspase inhibitory activity, pharmaceutical agent containing said compounds and for treating or preventing corneal endothelial symptoms, disorders, or diseases, and application of said pharmaceutical agent |
| AU2018283250B2 (en) | 2017-06-16 | 2022-09-01 | The Doshisha | mTOR-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereof |
| WO2019065838A1 (ja) | 2017-09-29 | 2019-04-04 | 参天製薬株式会社 | ピリジルアミノ酢酸化合物を含有する医薬 |
| KR20200103041A (ko) | 2017-12-21 | 2020-09-01 | 산텐 세이야꾸 가부시키가이샤 | 오미데네팍의 조합 |
| KR20200103719A (ko) | 2017-12-28 | 2020-09-02 | 산텐 세이야꾸 가부시키가이샤 | 피리딜아미노아세트산 화합물을 함유하는 의약 제제 |
| CN114761022B (zh) * | 2019-11-29 | 2024-02-13 | 千寿制药株式会社 | 药物组合物 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4960799A (en) * | 1988-09-13 | 1990-10-02 | Ciba-Geigy Corporation | Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use |
| US5631287A (en) * | 1994-12-22 | 1997-05-20 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
| JP3297969B2 (ja) * | 1994-12-26 | 2002-07-02 | ライオン株式会社 | 点眼剤 |
| CN1146423C (zh) * | 1998-07-14 | 2004-04-21 | 阿尔康实验室公司 | 前列腺素产品 |
| US6235781B1 (en) * | 1998-07-14 | 2001-05-22 | Alcon Laboratories, Inc. | Prostaglandin product |
| US20020009507A1 (en) * | 2000-01-19 | 2002-01-24 | Alcon Universal Ltd. | Use of polyethoxylated castor oil for the treatment of dry eye |
| JP2002356420A (ja) * | 2001-03-27 | 2002-12-13 | Santen Pharmaceut Co Ltd | 安定な水性液剤 |
| DK2264009T3 (en) * | 2008-03-12 | 2019-04-15 | Ube Industries | PYRIDYLAMINE ACEDIC ACID COMPOUND |
| SI2415763T1 (sl) | 2009-03-30 | 2016-05-31 | Ube Industries, Ltd. | Farmacevtski sestavek za zdravljenje ali preprečevanje glavkoma |
| JP2011057633A (ja) * | 2009-09-11 | 2011-03-24 | Ube Industries Ltd | ピリジルアミノ酢酸化合物を含有する医薬 |
| US20120058983A1 (en) * | 2010-09-02 | 2012-03-08 | Bayer Pharma Aktiengesellschaft | Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension |
| JP2014019650A (ja) * | 2012-07-13 | 2014-02-03 | Santen Pharmaceut Co Ltd | スルホンアミド化合物とタフルプロストの組み合わせ |
| US20140018350A1 (en) * | 2012-07-13 | 2014-01-16 | Asahi Glass Co., Ltd. | Combination of sulfonamide compound and tafluprost |
| US9339496B2 (en) * | 2012-07-13 | 2016-05-17 | Santen Pharmaceutical Co., Ltd. | Composition for treating or preventing glaucoma comprising a sulfonamide compound, and a beta-receptor antagonist |
| KR102074020B1 (ko) * | 2012-07-13 | 2020-02-05 | 산텐 세이야꾸 가부시키가이샤 | 술폰아미드 화합물의 조합 |
| GEP20186916B (en) * | 2014-01-10 | 2018-11-12 | Pharmaceutical Co Ltd Santen | Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical composition |
| KR101824829B1 (ko) * | 2014-01-10 | 2018-02-01 | 산텐 세이야꾸 가부시키가이샤 | 피리딜아미노아세트산 화합물을 포함하는 의약 제제 |
| MX2020003133A (es) * | 2014-01-10 | 2021-08-23 | Santen Pharmaceutical Co Ltd | Composicion farmaceutica que contiene compuesto de acido piridilaminoacetico. |
-
2015
- 2015-01-08 GE GEAP201514216A patent/GEP20186916B/en unknown
- 2015-01-08 MX MX2016009058A patent/MX2016009058A/es unknown
- 2015-01-08 CA CA2934612A patent/CA2934612C/en active Active
- 2015-01-08 KR KR1020207013304A patent/KR102230683B1/ko active IP Right Grant
- 2015-01-08 EA EA201691139A patent/EA031723B1/ru unknown
- 2015-01-08 EP EP21174649.0A patent/EP3888654B1/en active Active
- 2015-01-08 KR KR1020227036348A patent/KR20220146691A/ko active IP Right Grant
- 2015-01-08 MY MYPI2016001268A patent/MY166210A/en unknown
- 2015-01-08 SG SG11201605532YA patent/SG11201605532YA/en unknown
- 2015-01-08 WO PCT/JP2015/050333 patent/WO2015105134A1/ja active Application Filing
- 2015-01-08 KR KR1020167016400A patent/KR101858373B1/ko active IP Right Grant
- 2015-01-08 BR BR112016015911-0A patent/BR112016015911B1/pt active IP Right Grant
- 2015-01-08 CN CN201910493497.8A patent/CN110251516B/zh active Active
- 2015-01-08 KR KR1020217007751A patent/KR102458180B1/ko active IP Right Grant
- 2015-01-08 AU AU2015205268A patent/AU2015205268B2/en active Active
- 2015-01-08 TW TW104100527A patent/TWI612960B/zh active
- 2015-01-08 EP EP15735607.2A patent/EP3093021B1/en active Active
- 2015-01-08 ES ES21174649T patent/ES2953346T3/es active Active
- 2015-01-08 CN CN201580003056.5A patent/CN105828817B/zh active Active
- 2015-01-08 ES ES15735607T patent/ES2874547T3/es active Active
- 2015-01-08 JP JP2015002271A patent/JP6012775B2/ja active Active
- 2015-01-08 KR KR1020187012966A patent/KR102111157B1/ko active IP Right Grant
-
2016
- 2016-07-04 PH PH12016501327A patent/PH12016501327A1/en unknown
- 2016-07-07 IL IL246654A patent/IL246654B/en active IP Right Grant
- 2016-07-07 US US15/204,475 patent/US20160317512A1/en not_active Abandoned
- 2016-09-16 JP JP2016181739A patent/JP6449205B2/ja active Active
- 2016-10-28 HK HK16112476.0A patent/HK1224191A1/zh unknown
-
2018
- 2018-12-05 JP JP2018227964A patent/JP6793172B2/ja active Active
-
2019
- 2019-12-12 US US16/711,706 patent/US20200113880A1/en not_active Abandoned
-
2020
- 2020-11-09 JP JP2020186245A patent/JP7170020B2/ja active Active
-
2022
- 2022-10-31 JP JP2022174719A patent/JP2022189964A/ja active Pending
-
2023
- 2023-08-02 US US18/363,961 patent/US20230372316A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1224191A1 (zh) | 含有吡啶基氨基乙酸化合物和聚氧乙烯蓖麻油的藥物組合物 | |
| IL252477A0 (en) | 2-aminopyrimidine compound, pharmaceutical structure and its use | |
| IL253123B (en) | Preparations for administration through the skin and their uses | |
| HK1225655A1 (zh) | 包含azd9291的藥用組合物 | |
| EP3102200A4 (en) | Therapeutic compounds and compositions | |
| IL246447A0 (en) | A pharmaceutical preparation containing a pyridylaminoacetic acid compound | |
| IL246655B (en) | A medical preparation containing a pyridyl amino acetic acid compound | |
| ZA201703976B (en) | Dihydropyrimidine-2-one compounds and medicinal uses thereof | |
| EP3102585A4 (en) | Boronic acid esters and pharmaceutical formulations thereof | |
| EP3149099A4 (en) | Synthetic acid compositions and uses thereof | |
| ZA201703398B (en) | Pharmaceutical composition and methods | |
| PT3202759T (pt) | Derivado de alfa-aminoamida e composição farmacêutica contendo o mesmo | |
| EP3139741A4 (en) | Methods and compositions comprising 10-hydroxy-2-decenoic acid | |
| IL250729B (en) | A pyrazolothiazole compound and a drug containing it | |
| PL3184492T3 (pl) | Preparat antyseptyczny | |
| GB201417589D0 (en) | Pharmaceutical Formulations | |
| SG11201700122TA (en) | Pharmaceutical compound comprising 13 glycerides, formulation and application thereof | |
| GB201511863D0 (en) | Pharmaceutical compositions comprising hexaminolevulnic acid and methods of using the same |